Green light for GSK/Pfizer acquisition

The ACCC has announced that it will not oppose GSK’s proposed acquisition of Pfizer’s consumer healthcare business in Australia The proposed acquisition combines only the over-the-counter side of the two businesses, which include well-known analgesic products such as Panadol, Voltaren and Advil, as well as gastrointestinal and cold and flu products. The Australian Competition and